Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1330214.RApCAQqvCVVOt-g8Pbc3Q7lJwjazuv1ZZzedvz_ksiQA8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1330214.RApCAQqvCVVOt-g8Pbc3Q7lJwjazuv1ZZzedvz_ksiQA8130_assertion type Assertion NP1330214.RApCAQqvCVVOt-g8Pbc3Q7lJwjazuv1ZZzedvz_ksiQA8130_head.
- NP1330214.RApCAQqvCVVOt-g8Pbc3Q7lJwjazuv1ZZzedvz_ksiQA8130_assertion wasGeneratedBy ECO_0000203 NP1330214.RApCAQqvCVVOt-g8Pbc3Q7lJwjazuv1ZZzedvz_ksiQA8130_provenance.
- NP1330214.RApCAQqvCVVOt-g8Pbc3Q7lJwjazuv1ZZzedvz_ksiQA8130_assertion wasDerivedFrom befree-2016 NP1330214.RApCAQqvCVVOt-g8Pbc3Q7lJwjazuv1ZZzedvz_ksiQA8130_provenance.
- NP1330214.RApCAQqvCVVOt-g8Pbc3Q7lJwjazuv1ZZzedvz_ksiQA8130_assertion SIO_000772 8027225 NP1330214.RApCAQqvCVVOt-g8Pbc3Q7lJwjazuv1ZZzedvz_ksiQA8130_provenance.
- NP1330214.RApCAQqvCVVOt-g8Pbc3Q7lJwjazuv1ZZzedvz_ksiQA8130_assertion evidence source_evidence_literature NP1330214.RApCAQqvCVVOt-g8Pbc3Q7lJwjazuv1ZZzedvz_ksiQA8130_provenance.
- NP1330214.RApCAQqvCVVOt-g8Pbc3Q7lJwjazuv1ZZzedvz_ksiQA8130_assertion description "[Pit-1 is overexpressed (2.5- to 5-fold) in the PRL- and GH-secreting tumors, but to an extent consistent with the predominant cellular type of these adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1330214.RApCAQqvCVVOt-g8Pbc3Q7lJwjazuv1ZZzedvz_ksiQA8130_provenance.